The results of clinical trials revealed that the use of TNF-α-inhibitors (TNFαI) leads to fast control of inflammation, and, most significantly, slow radiographic progression, resulting in improved physical functioning of RA patients [1,22]. Here, TNF is linked to rheumatoid arthritis.